1-hydroxy-5,8-bis(2-((2-hydroxyethyl)amino)ethylamino)-9,10-anthracenedione has been researched along with Rheumatoid Arthritis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hamed, MS; Kamal, DE; Mostafa, DI; Sarhan, SA | 1 |
| Carvalho, PD; Hmamouchi, I; Machado, PM; Marreiros, A; Vieira-Sousa, E | 1 |
| Aw, MH; Dhanasekaran, P; Koh, LW; Lahiri, M; Mui-San Lim, R; Seet, D; Yeo, SI | 1 |
3 other study(ies) available for 1-hydroxy-5,8-bis(2-((2-hydroxyethyl)amino)ethylamino)-9,10-anthracenedione and Rheumatoid Arthritis
| Article | Year |
|---|---|
Validity and reliability of the Arabic version of the Self-Efficacy for Managing Chronic Disease scale in rheumatoid arthritis patients.
Topics: Arthritis, Rheumatoid; Chronic Disease; Humans; Mitoxantrone; Psychometrics; Quality of Life; Reproducibility of Results; Self Efficacy; Surveys and Questionnaires | 2022 |
Determinants of health-related quality of life in spondyloarthritis and rheumatoid arthritis - data from the COMOSPA and COMORA studies.
Topics: Arthritis, Rheumatoid; Cross-Sectional Studies; Humans; Quality of Life; Spondylarthritis; Surveys and Questionnaires | 2022 |
Smoking, but not use of complementary and alternative medicine predicts residual functional disability in patients with inflammatory arthritis on biologic disease-modifying anti-rheumatic drugs: Results from the Singapore National Biologics Register.
Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Biological Products; Cohort Studies; Complementary Therapies; Female; Humans; Male; Middle Aged; Prospective Studies; Singapore; Smoking; Young Adult | 2023 |